Safrycyn WOUND CREAM DRESSING WITH HYALURONIC ACID

Manufacturer
Lifsa Drugs LLC
Effective date
2025-08-01
Label type
PRESCRIPTION MEDICAL DEVICE LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:51:56

Label at a glance#

ProductSafrycyn WOUND CREAM DRESSING WITH HYALURONIC ACID
Label structure11 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

DESCRIPTION: Safrycyn is a soothing wound Cream that is formulated for the dressing and management of superficial wounds, minor abrasions, pressure ulcers stage II - IV, 1st and 2nd degree burns, including sunburns, and radiation dermatitis. When applied properly to a wound hyaluronic acid adheres to tissue to prevent damage while supplying moisture to the cells. Proven therapeutic moisturizers, lipids and glycerin and relieves dryness

INDICATIONS FOR USE

INDICATIONS & USAGE SECTION

Under the supervision of a healthcare professional, Safrycyn Cream is indicated to manage and relieve the burning, itching and pain experienced with various types of dermatoses, including atopic dermatitis, allergic contact dermatitis and radiation dermatitis. Safrycyn Cream also helps to relieve dry, waxy skin by maintaining a moist wound and skin environment, which is beneficial to the healing process.

DESCRIPTION

DESCRIPTION SECTION

Safrycyn Cream is a non-sterile, off-white, low odor, fragrance free, topical product. The Safrycyn Cream forms a physical barrier that helps to maintain a moist wound and skin environment. Safrycyn Cream is a prescription medical device.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Safrycyn Cream is contraindicated in persons with a known hypersensitivity to any of the components of the formulation.

WARNINGS

WARNINGS SECTION

External use only. Do not use this product if you are allergic to any of the ingredients. Avoid contact with eyes. KEEP OUT OF REACH OF CHILDREN.

FOR TOPICAL USE ONLY

NOT FOR OPTHALMIC USE

PRECAUTIONS AND OBSERVATIONS

PRECAUTIONS SECTION

• Safrycyn Cream does not contain a sunscreen and should not be used prior to extended exposure to the sun.
• If clinical signs of infection are present, appropriate treatment should be initiated; use of Safrycyn Cream may be continued during the anti-infective therapy.

INSTRUCTIONS FOR USE

INSTRUCTIONS FOR USE SECTION

Wound should be cleaned and disinfected. Apply Safrycyn cream to the affected area. Change the dressing based on the extent of the wound fluid, if wound exudates from primary and secondary dressings, change the dressing more frequently.

INGREDIENTS

INACTIVE INGREDIENT SECTION

Sodium Hyaluronate (0.2% w/w), Emulsifying Wax, Glycerol, Isopropyl palmitate, Potassium Phosphate Monobasic, Methyl Paraben, Propyl paraben and purified water

HOW SUPPLIED

HOW SUPPLIED SECTION

Safrycyn Cream is available in 42.5 grams Tube.

Rx Only CAUTION: Federal law restricts this device to sale by or on the order of a licensed healthcare practitioner.

Storage: Store below 85° F(30°C). Do not freeze. Keep tube tightly closed after use. Protect from freezing [see USP Controlled Room Temperature].

SPL UNCLASSIFIED SECTION

Distributed by:
Lifsa Drugs LLC
New Brunswick, NJ 08901

NC: TS/DRUGS/30/2005

Made in India

Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SAFRYCYN WOUND CREAMSAFRYCYN WOUND CREAM

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
efd58dcf-540a-4531-8766-e713129ca6f2Product name120250307

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
72336-819-28Safrycyn WOUND CREAM DRESSING WITH HYALURONIC ACID1 in 1 BOX11
72336-819-28Safrycyn WOUND CREAM DRESSING WITH HYALURONIC ACID42.5 g in 1 TUBE42.51

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
72336-819-28GM - Gram72336-819293cfa31-50b1-4c44-a5bd-19333902324212025-09-12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
72336-81972336-819-28

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CELISTAR MICRONEEDLING INFUSIONHYALURONATE SODIUMGuangdong Outeli Biotechnology Co., Ltd.53de46a7-3947-70a7-e063-6294a90ab8292026-06-09WarningsName fallback
generic name: HYALURONATE SODIUM

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.